Literature DB >> 19896468

Molecular mechanisms of the antagonistic action between AT1 and AT2 receptors.

Shin-ichiro Miura1, Yoshino Matsuo, Yoshihiro Kiya, Sadashiva S Karnik, Keijiro Saku.   

Abstract

Although angiotensin II (Ang II) binds to Ang II type 1 (AT(1)) and type 2 (AT(2)) receptors, AT(1) and AT(2) receptors have antagonistic actions with regard to cell signaling. The molecular mechanisms that underlie this antagonism are not well understood. We examined AT(1) and AT(2) receptor-induced signal cross-talk in the cytoplasm and the importance of the hetero-dimerization of AT(1) receptor with AT(2) receptor on the cell surface. AT(1) and AT(2) receptors showed antagonistic effects toward inositol phosphate production. AT(1) receptors mainly formed homo-dimers, rather than hetero-dimers with AT(2) receptor, on the cell surface as determined by immunoprecipitation, and subsequently induced cell signals. AT(2) receptor mainly formed homo-dimers, rather than hetero-dimers with AT(1) receptor, on the cell surface. The expression levels of homo-dimerized AT(1) receptor or AT(2) receptor on the cell surface did not change after treatment with Ang II, the AT(1) receptor antagonist telmisartan or the AT(2) receptor antagonist PD123319. Finally, AT(1) and AT(2) receptor-induced signals antagonized phospholipase C-beta(3) phosphorylation. In conclusion, Ang II-induced AT(1) receptor signals may be mainly blocked by AT(2) receptor signals through their negative cross-talk in the cytoplasm rather than by the hetero-dimerization of both receptors on the cell surface. The proper balance of the expression levels of AT(1) and AT(2) receptors might be critical for the antagonistic action between these receptors. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19896468      PMCID: PMC3891515          DOI: 10.1016/j.bbrc.2009.11.008

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  27 in total

1.  Interaction between Mas and the angiotensin AT1 receptor in the amygdala.

Authors:  O Von Bohlen und Halbach; T Walther; M Bader; D Albrecht
Journal:  J Neurophysiol       Date:  2000-04       Impact factor: 2.714

2.  The angiotensin II AT2 receptor is an AT1 receptor antagonist.

Authors:  S AbdAlla; H Lother; A M Abdel-tawab; U Quitterer
Journal:  J Biol Chem       Date:  2001-08-15       Impact factor: 5.157

3.  Constitutive activation of angiotensin II type 1 receptor alters the orientation of transmembrane Helix-2.

Authors:  Shin-Ichiro Miura; Sadashiva S Karnik
Journal:  J Biol Chem       Date:  2002-04-30       Impact factor: 5.157

Review 4.  International union of pharmacology. XXIII. The angiotensin II receptors.

Authors:  M de Gasparo; K J Catt; T Inagami; J W Wright; T Unger
Journal:  Pharmacol Rev       Date:  2000-09       Impact factor: 25.468

5.  Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosis.

Authors:  Said AbdAlla; Heinz Lother; Andreas Langer; Yasser el Faramawy; Ursula Quitterer
Journal:  Cell       Date:  2004-10-29       Impact factor: 41.582

6.  Two distinct mechanisms of angiotensin II-induced negative regulation of the mitogen-activated protein kinases in cultured cardiac myocytes.

Authors:  Y Hiroi; J Hiroi; S Kudoh; Y Yazaki; R Nagai; I Komuro
Journal:  Hypertens Res       Date:  2001-07       Impact factor: 3.872

7.  Angiotensin II type 2 receptor gene transfer downregulates angiotensin II type 1a receptor in vascular smooth muscle cells.

Authors:  Xue-Qing Jin; Noboru Fukuda; Jin-Zi Su; Yi-Mu Lai; Ryo Suzuki; Yoshiko Tahira; Hiroto Takagi; Yukihiro Ikeda; Katsuo Kanmatsuse; Hitoshi Miyazaki
Journal:  Hypertension       Date:  2002-05       Impact factor: 10.190

8.  Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness.

Authors:  S AbdAlla; H Lother; A el Massiery; U Quitterer
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

9.  Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients.

Authors:  J Stangier; C A Su; W Roth
Journal:  J Int Med Res       Date:  2000 Jul-Aug       Impact factor: 1.671

10.  Monomeric G protein-coupled receptor rhodopsin in solution activates its G protein transducin at the diffusion limit.

Authors:  Oliver P Ernst; Verena Gramse; Michael Kolbe; Klaus Peter Hofmann; Martin Heck
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

View more
  15 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 2.  Renin-angiotensin system in ureteric bud branching morphogenesis: insights into the mechanisms.

Authors:  Ihor V Yosypiv
Journal:  Pediatr Nephrol       Date:  2011-02-26       Impact factor: 3.714

3.  Diminazene aceturate prevents nephropathy by increasing glomerular ACE2 and AT2 receptor expression in a rat model of type1 diabetes.

Authors:  Santosh Kumar Goru; Almesh Kadakol; Vajir Malek; Anuradha Pandey; Nisha Sharma; Anil Bhanudas Gaikwad
Journal:  Br J Pharmacol       Date:  2017-08-11       Impact factor: 8.739

4.  Angiotensin II type 2 receptor-stimulated activation of plasma prekallikrein and bradykinin release: role of SHP-1.

Authors:  Liping Zhu; Oscar A Carretero; Jiang Xu; Luchen Wang; Pamela Harding; Nour-Eddine Rhaleb; James J Yang; Colin Sumners; Xiao-Ping Yang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-20       Impact factor: 4.733

5.  AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator.

Authors:  Ahmed Alhusban; Anna Kozak; Adviye Ergul; Susan C Fagan
Journal:  J Pharmacol Exp Ther       Date:  2012-12-04       Impact factor: 4.030

Review 6.  Dimerization of AT2 and Mas Receptors in Control of Blood Pressure.

Authors:  Sanket Patel; Tahir Hussain
Journal:  Curr Hypertens Rep       Date:  2018-05-01       Impact factor: 5.369

7.  Mechanisms involving Ang II and MAPK/ERK1/2 signaling pathways underlie cardiac and renal alterations during chronic undernutrition.

Authors:  Paulo A Silva; Gustavo Monnerat-Cahli; Amaury Pereira-Acácio; Ricardo Luzardo; Luzia S Sampaio; Marcia A Luna-Leite; Lucienne S Lara; Marcelo Einicker-Lamas; Rogério Panizzutti; Caroline Madeira; Leucio D Vieira-Filho; Carmen Castro-Chaves; Valdilene S Ribeiro; Ana D O Paixão; Emiliano Medei; Adalberto Vieyra
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

8.  Expression and cellular localization of the Mas receptor in the adult and developing mouse retina.

Authors:  Tuhina Prasad; Amrisha Verma; Qiuhong Li
Journal:  Mol Vis       Date:  2014-10-17       Impact factor: 2.367

9.  Attenuation of ligand-induced activation of angiotensin II type 1 receptor signaling by the type 2 receptor via protein kinase C.

Authors:  Takayuki Inuzuka; Yoichiro Fujioka; Masumi Tsuda; Mari Fujioka; Aya O Satoh; Kosui Horiuchi; Shinya Nishide; Asuka Nanbo; Shinya Tanaka; Yusuke Ohba
Journal:  Sci Rep       Date:  2016-02-09       Impact factor: 4.379

Review 10.  Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders.

Authors:  Ludovit Paulis; Sébastien Foulquier; Pawel Namsolleck; Chiara Recarti; Ulrike Muscha Steckelings; Thomas Unger
Journal:  Drugs       Date:  2016-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.